Editas Medicine to Host Conference Call Discussing Second Quarter 2021 Results and Corporate Update

Rhea-AI Summary

Editas Medicine, a genome editing leader, will host a conference call and webcast on August 4, 2021, at 8:00 a.m. ET. The purpose is to update stakeholders on corporate developments and Q2 2021 results. U.S. participants can join by dialing 877-407-0989, while international callers can dial 201-389-0921. A live webcast will be accessible on the company's website.

Editas focuses on innovative CRISPR/Cas9 and CRISPR/Cas12a technologies to develop genomic therapies targeting serious diseases globally.

CAMBRIDGE, Mass., July 28, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Wednesday, August 4, 2021, at 8:00 a.m. ET to provide a corporate update and results for the second quarter of 2021.

To access the conference call:

• U.S. callers should dial 877-407-0989 and international callers should dial 201-389-0921 approximately five minutes before the call begins.
• Participants should ask to be connected to the Editas Medicine earnings conference call.
  

A live webcast and replay of the conference call can also be accessed in the Investors section of the Editas Medicine website at https://www.editasmedicine.com/.

About Editas Medicine
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.

Contacts:
Media
Cristi Barnett
(617) 401-0113
cristi.barnett@editasmed.com

Investors
Ron Moldaver
(617) 401-9052
ir@editasmed.com

FAQ

When is the Editas Medicine Q2 2021 conference call?

Editas Medicine's Q2 2021 conference call is scheduled for August 4, 2021, at 8:00 a.m. ET.

How can I access the Editas Medicine earnings conference call?

To access the Editas Medicine earnings conference call, U.S. callers should dial 877-407-0989 and international callers should dial 201-389-0921.

Where can I watch the Editas Medicine conference call webcast?

The webcast for the Editas Medicine conference call can be viewed on their official website in the Investors section.

What is the focus of Editas Medicine?

Editas Medicine specializes in CRISPR technology to develop genomic medicines for serious diseases.